Belhaven Biopharma Raises $11M To Advance Nasdepi® For Anaphylaxis
22 Jan 2025 //
PHARMAWEB
Belhaven Biopharma To Reveal Nasdepi® Data At DDL 2024
11 Dec 2024 //
ACCESSWIRE
Belhaven Biopharma Presents Phase 1 Data on Epinephrine Powder
24 Oct 2024 //
ACCESSWIRE
Belhaven Biopharma’s Nasdepi® Named Finalist for Drug Delivery
22 Oct 2024 //
ACCESSWIRE
Belhaven Study Supports Dry Powder Nasal Epinephrine Delivery Solution
09 Jul 2024 //
ACCESSWIRE